GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC13184 structure
    GC13184PF 184
    CAS: 1187460-81-6
    Purity: >98%

    Le PF 184 est un puissant inhibiteur du facteur inhibiteur-κ B kinase 2 (IKK-2) avec une IC50 de 37 nM.

  • GC13200 structure
    GC13200Pam2CSK4 Biotin
    Purity: >98.00%

    biotinylated Pam2CSK4, a toll-like receptor 2/6 agonist

  • GC13203 structure
    GC132034-ethylphenyl sulfate
    CAS: 85734-98-1
    Purity: >97.00%

    4-ethylphenyl sulfate est un métabolite des microbes intestinaux qui est actif par voie orale, capable de traverser la barrière hémato-encéphalique.

  • GC13214 structure
    GC13214S-methyl-L-Thiocitrulline (hydrochloride)
    CAS: 209589-59-3
    Purity: >97.00%

    potent NOS inhibitor

  • GC13278 structure
    GC13278IKKε-IN-1
    CAS: 1292310-49-6
    Purity: >98%

    potent IKKε inhibitor

  • GC13292 structure
    GC13292EGTA
    CAS: 67-42-5
    Purity: >99.00%

    L'EGTA est un chélateur spécifique des ions calcium.

  • GC13345 structure
    GC13345NXY-059
    CAS: 168021-79-2
    Purity: >98.00%

    NXY-059 est un agent neuroprotecteur piégeant les radicaux libres, qui réduit les lésions oxydatifs en neutralisant les radicaux libres tout en atténuant la neuro-inflammation en protégeant l'intégrité de la barrière hémato-encéphalique.

  • GC13379 structure
    GC133791-Naphthyl 3,5-dinitrobenzoate
    CAS: 93261-39-3
    Purity: >98%

    dual 5-lipoxygenase and microsomal prostaglandin E synthase-1 inhibitor

  • GC13380 structure
    GC13380MEG (sulfate)
    CAS: 3979-00-8
    Purity: >99.50%

    L'hémisulfate de MEG (mercaptoéthylguanidine) est un inhibiteur puissant et sélectif de la NO synthase inductible (iNOS), avec des CE50 de 11,5, 110 et 60 μM pour iNOS, ecNOS et bNOS respectivement dans les homogénats de tissus.

  • GC13384 structure
    GC13384WS6
    CAS: 1421227-53-3
    Purity: >98.50%

    WS6 est une nouvelle petite molécule qui favorise la prolifération des cellules β dans les Îlots primaires de rongeurs et humains avec une CE50 de 0,28 uM (viabilité des cellules R7T1).

  • GC13386 structure
    GC13386ML351
    CAS: 847163-28-4
    Purity: >98.00%

    ML351 est un inhibiteur sélectif de la 15-lipoxygénase-1 (15-LOX-1; 12/15-LOX) ave une IC 50 de 200nM.

  • GC13427 structure
    GC13427(S)-Methylisothiourea sulfate
    CAS: 867-44-7
    Purity: >99.00%

    Le sulfate de (S)-méthylisothiourée est un inhibiteur puissant, sélectif et compétitif de l'oxyde nitrique synthase inductible (iNOS).

  • GC13429 structure
    GC13429Vanillic acid
    CAS: 121-34-6
    Purity: >98.50%

    L'acide vanillique est un agent aromatisant présent dans les plantes et les fruits comestibles, également présent dans Angelica sinensis.

  • GC13502 structure
    GC13502Cysteamine HCl
    CAS: 156-57-0
    Purity: >98.00%

    La cystéamine HCl (chlorhydrate de 2-aminoéthanethiol) est un agent actif par voie orale pour le traitement de la cystinose néphropathique et un antioxydant.

  • GC13506 structure
    GC13506Bradykinin (acetate)
    CAS: 6846-03-3
    Purity: >98%

    inflammatory mediator

  • GC13532 structure
    GC13532S-Isopropylisothiourea hydrobromide
    CAS: 4269-97-0
    Purity: >98%

    iNOS inhibitor

  • GC13563 structure
    GC135631400W dihydrochloride
    CAS: 214358-33-5
    Purity: >98.50%

    Le dichlorhydrate 1400W est un inhibiteur puissant et sélectif de la NO synthase inductible humaine avec des valeurs Ki de 7 nM.

  • GC13575 structure
    GC13575Pyrrolidinedithiocarbamate ammonium
    CAS: 5108-96-3
    Purity: >98.00%

    Le pyrrolidinedithiocarbamate d'ammonium (Ammonium pyrrolidinedithiocarbamate) est un inhibiteur sélectif et perméable À la barrière hémato-encéphalique (BBB) de NF-κB.

  • GC13616 structure
    GC13616Sodium ascorbate
    CAS: 134-03-2
    Purity: >99.00%

    Sodium ascorbate est un antioxydant endogène qui participe aux réactions d'hydroxylation dans l'organisme, favorise la formation des substances intercellulaires, aide à la synthèse des corticoïdes et influence la maturation des globules sanguins en stimulant la réduction de l'acide folique et l'absorption des ions ferriques. Sodium ascorbate possède également des effets antihistaminiques et inhibe la formation des nitrosamines.

  • GC13643 structure
    GC13643c-di-AMP
    CAS: 54447-84-6
    Purity: >95.00%

    C-di-AMP est un agoniste de STING qui se lie à cette protéine transmembranaire, activant ainsi la voie de signalisation TBK1-IRF3 et induisant par la suite la production d'interféron de type I IFN et de TNF.

  • GC13662 structure
    GC13662(±)-Lisofylline
    CAS: 6493-06-7
    Purity: >98.00%

    La (±)-lisofylline ((±)-lisophylline) est le racémate de la lisofylline.

  • GC13693 structure
    GC13693Omaveloxolone (RTA-408)
    CAS: 1474034-05-3
    Purity: >98.00%

    Omaveloxolone (RTA-408) est un modulateur de l'inflammation antioxydant (AIM) qui active Nrf2 et supprime l'oxyde nitrique (NO).

  • GC13765 structure
    GC13765EIT hydrobromide
    CAS: 1071-37-0
    Purity: >98%

    iNOS inhibitor

  • GC13795 structure
    GC13795Isobavachalcone
    CAS: 20784-50-3
    Purity: >98.00%

    A chalcone and flavonoid with diverse biological activities